CollPlant Biotechnologies Ltd. is a regenerative medicine company. It engages in the research, development, manufacture and marketing of medical products for tissue repair, initially for orthobiologics and advanced wound care markets. The company's products include VergenixSTR, VergenixFG, CollPlant Surgical Matrix. Collplant Holdings was founded by in June 2004 and is headquartered in Ness-Ziona, Israel.
Company profile
Ticker
CLGN
Exchange
Website
CEO
Yehiel Tal
Employees
Location
Former names
Collplant Holdings Ltd.
SEC CIK
Latest ownership filings
No filings